Generic Drug

(Image: Getty/Thida Ratn Caem Caeng  EyeEm)

Q&A

2018: An inflection point for generics

By Flora Southey

Generics drug portfolios are diversifying, prices are stabilising, and while competition remains intense, the worst of price erosion appears to be over, claims Clarivate Analytics executive.

Gettyimages/wildpixe

update - CEO: ideal model is two to four API plants and six to eight drug facilities

Teva confirms plan to reduce workforce by 14,000 to save $3bn

By Gareth Macdonald

Teva Pharmaceutical Industries will reduce its workforce by 14,000, rejig its generics portfolio and speed up optimization of its plant network as part of a $3bn (€2.5bn) cost saving plan.